Director/PDMR Shareholding

RNS Number : 2579C
GlaxoSmithKline PLC
27 April 2012
 



 

 

 

 

 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

I give below details of changes in interests in  American Depositary Shares (ADSs) of GlaxoSmithKline plc in respect of the under-mentioned Person Discharging Managerial Responsibility on 26 April 2012:-

 

Mr W C Louv

 Exercise of option over 2,684 ADSs, granted on 3 December 2002 under the GlaxoSmithKline Share Option Plan at a price of $37.25 per ADS, and sale of 2,684 ADSs at a price of $46.132 per ADS.

 

Exercise of option over 22,316 ADSs, granted on 3 December 2002 under the GlaxoSmithKline Share Option Plan at a price of $37.25 per ADS, and sale of 22,316 ADSs at a price of $46.123 per ADS.

 

 



The Company and the above-mentioned person were advised of these transactions on 27 April 2012.

 

This notification relates to transactions notified in accordance with Disclosure Rule 3.1.4R(1)(a).

 

 

V A Whyte

Company Secretary

 

27 April 2012

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSFDLFLLZFZBBE

Companies

GSK (GSK)
UK 100

Latest directors dealings